TB Alliance and GlaxoSmithKline Launch Broad Discovery Portfolio to Develop New TB Therapies
Program Commits to Affordable Pricing New York/London – March 21, 2005 – The Global Alliance for TB Drug Development (TB
Program Commits to Affordable Pricing New York/London – March 21, 2005 – The Global Alliance for TB Drug Development (TB
New York/Amsterdam – February 3, 2005 – The Department of Development Cooperation of the Netherlands Ministry of Foreign Affairs (DGIS),
The Global Alliance for TB Drug Development (TB Alliance) and Novartis Institute for Tropical Diseases (NITD) announced their plans to
NEW YORK, NY – OCT 20, 2004 – The Global Alliance for TB Drug Development (TB Alliance), a public-private partnership
New Donor Brings Support for Innovative Drug Development to $50 million The United States Agency for International Development (USAID), the
TB Alliance Adds New Member to Research & Development Team The Global Alliance for TB Drug Development (TB Alliance), a
TB Alliance Adds New Member to Research & Development Team The Global Alliance for TB Drug Development (TB Alliance), a
TB Alliance Bolsters Research & Development Team The TB Alliance has announced the appointment of Dr. Ann Ginsberg as Head
WHAT: Release of startling findings from the latest World Health Organization report on multi-drug-resistant strains in tuberculosis (MDR-TB): A total
Veteran of Academia and Industry brings 20-plus years of expertise to International Public-Private Partnership The TB Alliance has announced the